Charles Schwab Investment Management Inc. Increases Holdings in Teleflex Incorporated (NYSE:TFX)

Charles Schwab Investment Management Inc. increased its position in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 1.1% in the 3rd quarter, Holdings Channel reports. The firm owned 393,053 shares of the medical technology company’s stock after purchasing an additional 4,415 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Teleflex were worth $77,200,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. grew its holdings in Teleflex by 2.5% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,231 shares of the medical technology company’s stock valued at $792,000 after buying an additional 54 shares in the last quarter. HighTower Advisors LLC grew its holdings in Teleflex by 2.2% in the 1st quarter. HighTower Advisors LLC now owns 4,678 shares of the medical technology company’s stock valued at $1,655,000 after buying an additional 99 shares in the last quarter. Private Advisor Group LLC purchased a new stake in Teleflex in the 1st quarter valued at $455,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in Teleflex by 6.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,268 shares of the medical technology company’s stock valued at $2,224,000 after buying an additional 388 shares in the last quarter. Finally, Yousif Capital Management LLC grew its holdings in Teleflex by 2.7% in the 1st quarter. Yousif Capital Management LLC now owns 7,158 shares of the medical technology company’s stock valued at $2,540,000 after buying an additional 190 shares in the last quarter. 97.15% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Price Performance

TFX opened at $252.73 on Tuesday. The stock’s 50-day moving average price is $246.20 and its 200 day moving average price is $222.86. Teleflex Incorporated has a 12-month low of $177.63 and a 12-month high of $276.43. The company has a current ratio of 3.58, a quick ratio of 2.51 and a debt-to-equity ratio of 0.45. The firm has a market cap of $11.88 billion, a price-to-earnings ratio of 29.63, a PEG ratio of 2.29 and a beta of 1.14.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on TFX shares. Truist Financial upped their target price on Teleflex from $221.00 to $270.00 and gave the company a “hold” rating in a report on Friday, December 22nd. Royal Bank of Canada upped their target price on Teleflex from $228.00 to $272.00 and gave the company an “outperform” rating in a report on Friday, January 12th. JMP Securities decreased their price target on Teleflex from $315.00 to $285.00 and set a “market outperform” rating on the stock in a research note on Friday, November 3rd. Morgan Stanley raised Teleflex from an “equal weight” rating to an “overweight” rating and set a $261.00 price target on the stock in a research note on Monday, December 4th. Finally, Piper Sandler upped their price target on Teleflex from $210.00 to $225.00 and gave the company a “neutral” rating in a research note on Monday, November 6th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $269.30.

Check Out Our Latest Stock Analysis on Teleflex

Insider Buying and Selling

In related news, CEO Liam Kelly sold 26,256 shares of the stock in a transaction dated Wednesday, December 27th. The stock was sold at an average price of $250.23, for a total transaction of $6,570,038.88. Following the transaction, the chief executive officer now owns 18,470 shares of the company’s stock, valued at approximately $4,621,748.10. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other Teleflex news, CFO Thomas E. Powell sold 13,952 shares of the stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $222.88, for a total value of $3,109,621.76. Following the sale, the chief financial officer now owns 14,384 shares of the company’s stock, valued at approximately $3,205,905.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Liam Kelly sold 26,256 shares of the stock in a transaction dated Wednesday, December 27th. The shares were sold at an average price of $250.23, for a total value of $6,570,038.88. Following the completion of the sale, the chief executive officer now directly owns 18,470 shares in the company, valued at approximately $4,621,748.10. The disclosure for this sale can be found here. 1.41% of the stock is owned by corporate insiders.

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Stories

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.